- Home
- RMNI vs FENC Comparison
RMNI vs FENC Comparison
Compare RMNI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMNI | FENC |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.1M | 266.4M |
| IPO Year | 2015 | 2010 |
Fundamental Metrics
Financial Performance| Metric | RMNI | FENC |
|---|---|---|
| Price | $3.98 | $6.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $5.00 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 305.1K | 133.5K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 197.50 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $431,496,000.00 | $44,642,000.00 |
| Revenue This Year | $6.02 | $65.12 |
| Revenue Next Year | $5.50 | $41.08 |
| P/E Ratio | $8.74 | ★ N/A |
| Revenue Growth | ★ 5.33 | N/A |
| 52 Week Low | $2.87 | $5.65 |
| 52 Week High | $5.38 | $9.92 |
Technical Indicators
Market Signals| Indicator | RMNI | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 69.61 | 47.05 |
| Support Level | $3.91 | $5.65 |
| Resistance Level | $4.15 | $8.09 |
| Average True Range (ATR) | 0.13 | 0.34 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 85.63 | 48.51 |
Price Performance
Historical ComparisonAbout RMNI Rimini Street Inc. (DE)
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.